![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 42741 |
FusionGeneSummary for ZFAND2A_ABHD3 |
![]() |
Fusion gene information | Fusion gene name: ZFAND2A_ABHD3 | Fusion gene ID: 42741 | Hgene | Tgene | Gene symbol | ZFAND2A | ABHD3 | Gene ID | 90637 | 171586 |
Gene name | zinc finger AN1-type containing 2A | abhydrolase domain containing 3 | |
Synonyms | AIRAP | LABH3 | |
Cytomap | 7p22.3 | 18q11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | AN1-type zinc finger protein 2Aarsenite inducible RNA associated proteinzinc finger, AN1-type domain 2A | phospholipase ABHD3abhydrolase domain-containing protein 3alpha/beta hydrolase domain containing protein 3lung alpha/beta hydrolase 3 | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | Q8N6M9 | Q8WU67 | |
Ensembl transtripts involved in fusion gene | ENST00000401903, ENST00000316495, ENST00000478137, | ENST00000289119, ENST00000580981, ENST00000578270, ENST00000579875, | |
Fusion gene scores | * DoF score | 4 X 4 X 2=32 | 4 X 5 X 5=100 |
# samples | 4 | 7 | |
** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/100*10)=-0.514573172829758 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ZFAND2A [Title/Abstract] AND ABHD3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BE074612 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000401903 | ENST00000289119 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000401903 | ENST00000580981 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000401903 | ENST00000578270 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000401903 | ENST00000579875 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000316495 | ENST00000289119 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000316495 | ENST00000580981 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000316495 | ENST00000578270 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000316495 | ENST00000579875 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000478137 | ENST00000289119 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000478137 | ENST00000580981 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000478137 | ENST00000578270 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
intron-intron | ENST00000478137 | ENST00000579875 | ZFAND2A | chr7 | 1193724 | + | ABHD3 | chr18 | 19261747 | - |
Top |
FusionProtFeatures for ZFAND2A_ABHD3 |
![]() |
Hgene | Tgene |
ZFAND2A | ABHD3 |
Phospholipase that may play a role in phospholipidsremodeling. May selectively cleave myristate (C14)-containingphosphatidylcholines through its predominant phospholipase 1activity, cleaving preferentially acyl groups in sn1 position. Inparallel, may have a minor phospholipase 2 activity acting on acylgroups in position sn2. In addition to (C14)-containingphosphatidylcholines, may also act on other medium-chain-containing and oxidatively truncated phospholipids.{ECO:0000269|PubMed:21926997}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ZFAND2A_ABHD3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ZFAND2A_ABHD3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ZFAND2A_ABHD3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ZFAND2A_ABHD3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |